MedTrace Logo

Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif

NCT02377323 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 296

Last updated 2017-05-24

No results posted yet for this study

Summary

The purpose of this study is to determine whether Rebif has an impact on employment status, quality of life and cognition.

Conditions

Interventions

OTHER

MACFIMS

Cognitive evaluation of 50 participants

OTHER

MSQoL-54

Quality of life questionnaires

Sponsors & Collaborators

  • EMD Serono Canada Inc.

    collaborator INDUSTRY

  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • Pierre Duquette, MD · Centre hospitalier de l'Université de Montréal (CHUM)

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-05-31
Completion
2016-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02377323 on ClinicalTrials.gov